GEHC: GE HealthCare Technologies EV/EBITDA Multiple

Corporate emblem and logo of GE HealthCare Technologies (GEHC)

GE HealthCare leads the imaging sector through the integration of AI into diagnostics. The synergy between smart systems and a massive order backlog determines the current valuation based on the EV/EBITDA multiple, where 12.22 is recorded as the baseline value. However, component inflation, currency risks, and a potential stagnation in healthcare facility capital expenditures are weighing on the share price.

GE HealthCare Inc. - GEHC Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/12/2026)

Summary analytical data breakdowns for gehealthcare.com (GEHC)

- stock price and consensus target price:
Stock Quotes GE Healthcare Corp|GEHC - Analyst Forecast Prices
- market capitalization information:
Market Capitalization GE HealthCare Inc.|GEHC - Company Buyout Price
- issuer book value statistics:
Book Value per Share GE HealthCare|GEHC - Company Net Assets|Market Cap to Net Assets Ratio gehealthcare.com|GEHC - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity GE HealthCare|GEHC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital GE HealthCare Technologies|GEHC - Company Cumulative Debt|Debts to Book Capitalization GE HealthCare Inc.|GEHC - Company Long-Term Indebtedness|Company Short-Term Debts GE HealthCare|Quick Ratio gehealthcare.com
- financial results and valuation multiples details:
GEHC - Net Income|Projected Future Earnings GE HealthCare|GEHC - P/E Multiple|Future Price to Earnings GE HealthCare|GEHC - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio GE HealthCare Inc.|GEHC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) GE HealthCare|GEHC - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months gehealthcare.com|GEHC - Net earnings per share change in current year|Expected earnings per share growth for next year GE HealthCare
Initial company analysis:GE Healthcare Corp GEHC
Original product of gehealthcare.com

GE HealthCare maintains stability by scaling AI solutions that mitigate the impact of high equipment costs on margins. By analyzing the company's current EV/EBITDA multiple on GURU.Markets, an investor assesses the business value relative to its operating profit before depreciation and interest. The trend of this ratio filters out market noise, revealing the actual macroeconomic sensitivity of the assets. A decline in this metric signals that the business is undervalued while maintaining potential for operating leverage.

Competitor analysis for GE HealthCare

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|Mettler-Toledo International - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio waters.com WAT|TECH: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bruker Corp|Enterprise Value to EBITDA Ratio AZTA|VREX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Semler Scientific, Inc. (SMLR)|Enterprise Value to EBITDA Ratio butterflynetwork.com BFLY|EV/EBITDA Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Company Value to EBITDA|Nanox - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)